Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Journal of Investigative Medicine High Impact Case Reports|October 2, 2015
Belatacept for Maintenance Immunosuppression in Lung TransplantationChristine Hui, Ryan Kern, David Wojciechowski, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 7, 2013
Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: initial report on the use of postoperative Technetium-99 m-mercaptoacetyltriglycine scansParsia A Vagefi, Jesse J Qian, David M Carlson, et al.
Artificial Organs|April 20, 2019
Process of selecting and educating HCV-uninfected kidney waiting-list candidates for HCV-infected kidney transplantationMeghan E Sise, David Wojciechowski, Donald F Chute, et al.
Annals of Transplantation|July 2, 2021
Clinical Rationale for a Routine Testing Schedule Using Donor-Derived Cell-Free DNA After Kidney TransplantationAkshta Pai, Joshua T Swan, David Wojciechowski, et al.
Annals of Surgery|May 28, 2025
Being Waitlisted is not Enough: Identification of Pseudo-access to Kidney Transplantation in the United StatesLauren E Matevish, Madhukar S Patel, Deepa Ravindra, et al.
Journal of Biosciences and Medicines|December 20, 2016
Voriconazole-Induced Periostitis & Enthesopathy in Solid Organ Transplant Patients: Case ReportsMonica Sircar, Camille Kotton, David Wojciechowski, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|April 26, 2018
Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipientsMeghan E Sise, Donald F Chute, Jenna L Gustafson, et al.
Transplantation Proceedings|September 1, 2021
Association of Inflammatory Biomarkers with Immunosuppression Management and Outcomes in Kidney Transplant Recipients with COVID-19Nashila AbdulRahim, Meredith McAdams, Pin Xu, et al.
Journal of Nephrology|May 25, 2021
Assessing accuracy of estimated dry weight in dialysis patients post transplantation: the kidney knows bestMichael J Germain, Barbara A Greco, Spencer Hodgins, et al.
Transplantation|March 12, 2025
Phase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21)Naotsugu Ichimaru, Yoichiro Natori, Rita R Alloway, et al.
Pageof 7